NGT BioPharma Consultants

Meet the Team

Our team of biopharmaceutical drug development leaders, industry professionals, strategic thinkers and transactional experts oversee a network of over 200 top-tier consultants whose experience and expertise span the essential drug development disciplines beginning in Late Discovery and encompassing Preclinical and Clinical Development, Commercialization/Launch and Life-Cycle Management.

Business Operations

Michael K. O’Brien, PhD
President & CEO
Dave Lowenschuss
Dave Lowenschuss
Legal Counsel

Biopharmaceutical Drug Development

Ronay LeBlanc, MA
Quality & Compliance
Michael Placke, PhD, DABT
Nonclinical Sciences
Paolo Rampichini, BE, MBA
Global Supply Chain
Mark Buswell
Mark Buswell
Digital Innovation
Daniel Schaufelberger, PhD
Daniel Schaufelberger, PhD
Pediatric Center of Excellence

Transactional Business Development & Due Diligence

Haresh Mirchandani
Haresh Mirchandani, PhD, MBA
Business Development Strategies
Scott Lundeen
Scott Lundeen, PhD
Due Diligence
Malcolm Berry, PhD - Multi-Stage Continuous Processing for APIs
 
Malcolm Berry, PhD
API Continuous Processing
Michael Placke, NGT Biopharma Consultants
 
Michael Placke, PhD, DABT
Nonclinical Development
and Drug Safety